Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Dr. Kasiani Myers: Acquired and Inheirited Bone Marrow Failure

    ... and has been functionally destroyed. We do use chemotherapy for both categories of aplastic anemia, but the type and strength of this chemotherapy is often very different. The majority of inherited marrow failures ...

    Interview last updated 02/14/2017 - 8:34am.

  2. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... is to test the safety and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent ... induction and at least one course of consolidation chemotherapy pretransplant Patients must have a Karnofsky ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  3. Selinexor (KPT-330) in Older Patients With Relapsed/Refractory AML (SOPRA)

    ... AML who are ineligible for standard intensive chemotherapy and/or transplantation. In the Selinexor in Older Patient with ... and are currently deemed unfit for intensive chemotherapy . ECOG ≤ 2. Must have available archival or recently ...

    Clinical Trial last updated 08/26/2016 - 9:21am.

  4. Tom Coccagna

    ... appointments, bone marrow biopsies, CBCs, transfusions, chemotherapy and a clinical trial became my new reality. For ... stops responding to it, what then? More transfusions? More chemotherapy? A bone marrow transplant? When you have a life-threatening ...

    Patient Chronicle last updated 02/14/2017 - 9:03am.

  5. Fatigue

    ... normal muscle function. Other causes may include: Chemotherapy and other medications and treatments Sleep disturbances ...

    Page last updated 02/01/2017 - 11:52am.

  6. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... called natural killer (NK) cells that can be given with chemotherapy and a stem cell transplant to patients with AML and ... kill cancer cells that remain in your body after your last chemotherapy treatment. The NK cells will be separated from blood from a ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  7. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... genetically changed immune cells, called T-cells, after chemotherapy will improve the response to a stem cell transplant . ... received an allogeneic stem cell transplant . The chemotherapy participant will be given on study is fludarabine , ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  8. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... - To see if high doses of palifermin before chemotherapy are safe, prevent chronic GVHD, and improve immune function ... catheter if they do not have one. Have 1 3 rounds of chemotherapy. Take more tests to make sure they can have the transplant, ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  9. Intra-Osseous Co-Transplant of UCB and hMSC

    ... with hematologic malignancies. Giving low doses of chemotherapy and total-body irradiation before a co-transplant of donor ... by flow cytometry after 2 or more cycles of chemotherapy No complete remission (CR) within 4 weeks of initial ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  10. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... cells that remain in participant's body after their last chemotherapy treatment. The NK cells will be separated from umbilical cord ... flow cytometry ), secondary leukemia from prior chemotherapy and/or arising from MDS, any disease beyond first remission. ...

    Clinical Trial last updated 06/06/2016 - 10:28am.